Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-21-000469
Filing Date
2021-07-12
Accepted
2021-07-12 15:49:27
Documents
1
Group Members
ALI BEHBAHANIANTHONY A. FLORENCE, JR.CARMEN CHANGEDWARD T. MATHERSFOREST BASKETTJOSHUA MAKOWERLIZA LANDSMANMOHAMAD H. MAKHZOUMINEA 17 GP, LLCNEA PARTNERS 17, L.P.PAUL WALKERPETER W. SONSINIRICK YANGSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 17, L.P. / MONTE ROSA THERAPEUTICS, INC. -- SCHEDULE 1 nea17-monte_18511.htm SC 13D 528738
  Complete submission text file 0001072613-21-000469.txt   530737
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 17, L.P. (Filed by) CIK: 0001768564 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Subject) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92649 | Film No.: 211085496
SIC: 2836 Biological Products, (No Diagnostic Substances)